Vertex Pharmaceuticals, Inc. (VRTX)
436.58
-0.37
(-0.08%)
USD |
NASDAQ |
May 18, 16:00
436.93
+0.35
(+0.08%)
After-Hours: 20:00
Vertex Pharmaceuticals Research and Development Expense (Quarterly) : 961.60M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.719B |
| Biogen, Inc. | 471.10M |
| Gilead Sciences, Inc. | 1.354B |
| Regeneron Pharmaceuticals, Inc. | 1.420B |
| Moderna, Inc. | 590.00M |